rdf:type |
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0007784,
umls-concept:C0030705,
umls-concept:C0079459,
umls-concept:C0086418,
umls-concept:C0205178,
umls-concept:C0205721,
umls-concept:C0210630,
umls-concept:C0355642,
umls-concept:C0376249,
umls-concept:C0445202,
umls-concept:C0677582,
umls-concept:C0876926,
umls-concept:C1257890,
umls-concept:C1280500,
umls-concept:C2603343
|
pubmed:issue |
4
|
pubmed:dateCreated |
1998-5-14
|
pubmed:abstractText |
To determine whether the use of prophylactic recombinant human granulocyte colony-stimulating factor (filgrastim) reduces the frequency of nosocomial infections in patients with either acute traumatic brain injury or cerebral hemorrhage.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0090-3493
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
748-54
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9559614-APACHE,
pubmed-meshheading:9559614-Adolescent,
pubmed-meshheading:9559614-Adult,
pubmed-meshheading:9559614-Aged,
pubmed-meshheading:9559614-Aged, 80 and over,
pubmed-meshheading:9559614-Bacteremia,
pubmed-meshheading:9559614-Brain Injuries,
pubmed-meshheading:9559614-Cerebral Hemorrhage,
pubmed-meshheading:9559614-Cross Infection,
pubmed-meshheading:9559614-Dose-Response Relationship, Drug,
pubmed-meshheading:9559614-Double-Blind Method,
pubmed-meshheading:9559614-Female,
pubmed-meshheading:9559614-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:9559614-Humans,
pubmed-meshheading:9559614-Leukocyte Count,
pubmed-meshheading:9559614-Male,
pubmed-meshheading:9559614-Middle Aged,
pubmed-meshheading:9559614-Neutrophils,
pubmed-meshheading:9559614-Pneumonia,
pubmed-meshheading:9559614-Recombinant Proteins,
pubmed-meshheading:9559614-Urinary Tract Infections
|
pubmed:year |
1998
|
pubmed:articleTitle |
Effect of prophylactic administration of recombinant human granulocyte colony-stimulating factor (filgrastim) on the frequency of nosocomial infections in patients with acute traumatic brain injury or cerebral hemorrhage. The Filgrastim Study Group.
|
pubmed:affiliation |
Department of Anesthesiology, University of Massachusetts Medical Center, Worcester 01655, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study,
Clinical Trial, Phase II
|